(firstQuint)HER2 Circulating Tumor Cells in Gastric Cancer.

 We propose to survey the frequency of HER2 (+) CTC in order to lay groundwork for future clinical trials incorporating Her-2 targeted agents in gastric cancer.

 Blood samples will be collected from metastatic gastric cancer patients.

.

 HER2 Circulating Tumor Cells in Gastric Cancer@highlight

The investigators propose to survey the frequency of HER2 (+) CTC in order to lay groundwork for future clinical trials incorporating Her-2 targeted agents in gastric cancer.

